These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8665150)
1. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Cinatl J; Scholz M; Weber B; Cinatl J; Rabenau H; Markus BH; Encke A; Doerr HW Transpl Immunol; 1995 Dec; 3(4):313-20. PubMed ID: 8665150 [TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Cinatl J; Cinatl J; Rabenau H; Gümbel HO; Kornhuber B; Doerr HW Antiviral Res; 1994 Sep; 25(1):73-7. PubMed ID: 7811060 [TBL] [Abstract][Full Text] [Related]
3. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Scholz M; Cinatl J; Gross V; Vogel JU; Blaheta RA; Freisleben HJ; Markus BH; Doerr HW Transplantation; 1996 Jun; 61(12):1763-70. PubMed ID: 8685957 [TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid. Cinatl J; Hoffmann F; Cinatl J; Weber B; Scholz M; Rabenau H; Stieneker F; Kabickova H; Blasko M; Doerr HW Antiviral Res; 1996 Jun; 31(1-2):23-34. PubMed ID: 8793006 [TBL] [Abstract][Full Text] [Related]
5. [Selective inhibition of replication of human cytomegalovirus by desferrioxamine in vitro and in vivo (case report)]. Gümbel H; Cinatl J; Rabenau H; Vogel JU; Doerr HW; Ohrloff C Ophthalmologe; 1995 Dec; 92(6):840-3. PubMed ID: 8563434 [TBL] [Abstract][Full Text] [Related]
6. Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Zhang WJ; Frei B Free Radic Biol Med; 2003 Mar; 34(6):674-82. PubMed ID: 12633744 [TBL] [Abstract][Full Text] [Related]
7. Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirus-infected rat liver allografts with rejection. Martelius T; Scholz M; Krogerus L; Höckerstedt K; Loginov R; Bruggeman C; Cinatl J; Doerr HW; Lautenschlager I Transplantation; 1999 Dec; 68(11):1753-61. PubMed ID: 10609953 [TBL] [Abstract][Full Text] [Related]
8. Modulation of HLA class I antigen and ICAM-2 on endothelial cells after in vitro infection with human cytomegalovirus. Shahgasempour S; Woodroffe SB; Garnett HM Immunol Cell Biol; 1998 Jun; 76(3):217-21. PubMed ID: 9682965 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. Dengler TJ; Raftery MJ; Werle M; Zimmermann R; Schönrich G Transplantation; 2000 Mar; 69(6):1160-8. PubMed ID: 10762222 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Scholz M; Hamann A; Blaheta RA; Auth MK; Encke A; Markus BH Hum Immunol; 1992 Dec; 35(4):230-8. PubMed ID: 1284062 [TBL] [Abstract][Full Text] [Related]
11. Lymphocytes induce enhanced expression of HLA class I antigens on cytomegalovirus-infected syngeneic human endothelial cells. Scholz M; Blaheta RA; Cinatl J; Encke A; Doerr HW; Markus BH Hum Immunol; 1995 Nov; 44(3):136-44. PubMed ID: 8666550 [TBL] [Abstract][Full Text] [Related]
12. Effect of human cytomegalovirus and glucose on adhesion molecules expression in cultured human endothelial cells. Altannavch TS; Roubalová K; Kucera P; Juzová O; Andel M Acta Virol; 2002; 46(3):183-6. PubMed ID: 12580382 [TBL] [Abstract][Full Text] [Related]
13. Allograft rejection-related gene expression in the endothelial cells of renal transplantation recipients after cytomegalovirus infection. Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Tian XH; Xiang HL; Hou J J Zhejiang Univ Sci B; 2009 Nov; 10(11):820-8. PubMed ID: 19882756 [TBL] [Abstract][Full Text] [Related]
14. In vitro induction of endothelial adhesion molecule and MHC antigen expression by cytomegalovirus-activated CD4+ T cells. Waldman WJ; Knight DA; Adams PW; Orosz CG; Sedmak DD Transplant Proc; 1995 Feb; 27(1):1269-71. PubMed ID: 7533377 [No Abstract] [Full Text] [Related]
15. Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection. Sindre H; Haraldsen G; Beck S; Hestdal K; Kvale D; Brandtzaeg P; Degré M; Rollag H Scand J Immunol; 2000 Apr; 51(4):354-60. PubMed ID: 10736107 [TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Odeberg J; Cerboni C; Browne H; Kärre K; Möller E; Carbone E; Söderberg-Nauclér C Scand J Immunol; 2002 Feb; 55(2):149-61. PubMed ID: 11896931 [TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. Gerna G; Percivalle E; Baldanti F; Sozzani S; Lanzarini P; Genini E; Lilleri D; Revello MG J Virol; 2000 Jun; 74(12):5629-38. PubMed ID: 10823870 [TBL] [Abstract][Full Text] [Related]
18. Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Shahgasempour S; Woodroffe SB; Garnett HM Microbiol Immunol; 1997; 41(2):121-9. PubMed ID: 9087954 [TBL] [Abstract][Full Text] [Related]
19. The effect of short-chain fatty acids on the susceptibility of human umbilical vein endothelial cells to human cytomegalovirus infection. Wu QH; Ascensao J; Almeida G; Forman SJ; Shanley JD J Virol Methods; 1994 Apr; 47(1-2):37-50. PubMed ID: 8051232 [TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation. Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]